Vimarsana
Biggest News Aggregation in the World

Endothelial Cell News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Endothelial Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Endothelial Cell Today - Breaking & Trending Today

Anger damages blood vessel function, raising heart disease risk - Vimarsana News

Anger damages blood vessel function, raising heart disease risk

A recent study in the Journal of the American Heart Association reveals that provoked anger, but not sadness or anxiety, acutely impairs endothelial function, shedding light on the link between anger and cardiovascular events.

Global Sepsis Therapeutics Strategic Research Report 2024: - Vimarsana News

Global Sepsis Therapeutics Strategic Research Report 2024:

Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The

Study shines light on partial endothelial-to-mesenchymal transition in the tumor microenvironment - Vimarsana News

Study shines light on partial endothelial-to-mesenchymal transition in the tumor microenvironment

Endothelial-mesenchymal transition (EndoMT, also termed as EndMT), a biological process resulting in the formation of mesenchymal (or lineage-committed) phenotypes from endothelial cells (lining blood vessels), plays a crucial role in tumor progression.

Study identifies α-MSH as therapeutic candidate for corneal endothelial disease - Vimarsana News

Study identifies α-MSH as therapeutic candidate for corneal endothelial disease

Findings from a pioneering study in The American Journal of Pathology, published by Elsevier, reveal that administration of the neuropeptide α-melanocyte-stimulating hormone (α-MSH) promotes corneal healing and restores normal eye function to an otherwise degenerating and diseased cornea by providing protection against cell death and promoting cell regeneration.

Angelica gigas extract emerges as a potential treatment for vascular disease - Vimarsana News

Angelica gigas extract emerges as a potential treatment for vascular disease

A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 23, entitled, "Angelica gigas extract inhibits acetylation of eNOS via IRE1α sulfonation/RIDD-SIRT1-mediated posttranslational modification in vascular dysfunction."